Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 407 Records) |
| Query Trace: Lung Neoplasms and MET[original query] |
|---|
| Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification. Technology in cancer research & treatment 2022 9 21 15330338221128414. Sun Dantong, Tao Junyan, Yan Weihua, Zhu Jingjuan, Zhou Hai, Sheng Yingying, Xue Chaofan, Li Hong, Hou Hel |
| The Impact of Targetable Mutations on Clinical Outcomes of Metastatic Epidural Spinal Cord Compression in Patients With Non-Small-Cell Lung Cancer Treated With Hybrid Therapy (Surgery Followed by Stereotactic Body Radiation Therapy). Neurosurgery 2022 12 92 (3): 557-564. Chakravarthy Vikram B, Schachner Benjamin, Amin Anubhav G, Reiner Anne S, Yamada Yoshiya, Schmitt Adam, Higginson Daniel S, Laufer Ilya, Bilsky Mark H, Barzilai O |
| Validation of an LC-MS/MS method for the determination of sotorasib, a KRAS inhibitor, in human plasma. Bioanalysis 2022 12 14 (19): 1281-1292. Wong Philip, Akrami Anna, Houk Brett, Vuu Irene, James Christopher |
| Budget impact analysis of next-generation sequencing versus sequential single-gene testing in Japanese patients with advanced non-small-cell lung cancer. Respiratory investigation 2022 12 61 (1): 61-73. Matsuda Hiroyuki, Ogawa Toru, Sadatsuki Yasunari, Tsujino Toshiaki, Wada Shingo, Kim Seok-Won, Hatanaka Yuta |
| Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study. Therapeutic advances in medical oncology 2022 11 14 17588359221133546. Yu Yongfeng, Ren Yongxin, Fang Jian, Cao Lejie, Liang Zongan, Guo Qisen, Han Sen, Ji Zimei, Wang Ye, Sun Yulan, Chen Yuan, Li Xingya, Xu Hua, Zhou Jianying, Jiang Liyan, Cheng Ying, Han Zhigang, Shi Jianhua, Chen Gongyan, Ma Rui, Fan Yun, Sun Sanyuan, Jiao Longxian, Jia Xiaoyun, Wang Linfang, Lu Puhan, Xu Qian, Luo Xian, Su Weiguo, Lu Sh |
| The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study. JTO clinical and research reports 2022 11 3 (12): 100427. Benjamin David J, Chen Shuai, Eldredge Joanna B, Schokrpur Shiruyeh, Li Debory, Quan Zhikuan, Chan Jason W, Cummings Amy L, Daly Megan E, Goldman Jonathan W, Gubens Matthew A, Harris Jeremy P, Onaitis Mark W, Zhu Viola W, Patel Sandip P, Kelly Kar |
| Dramatic response to neoadjuvant savolitinib in marginally resectable lung adenocarcinoma with MET exon 14 skipping mutation: A case report and literature review. Frontiers in oncology 2022 11 12 1006634. Tian Jiangfang, Lin Zhen, Chen Yueyun, Fu Yang, Ding Zhen |
| A large-scale prospective concordance study of plasma- and tissue-based next-generation targeted sequencing for advanced non-small cell lung cancer (LC-SCRUM-Liquid). Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Oct . Sugimoto Akira, Matsumoto Shingo, Udagawa Hibiki, Itotani Ryo, Usui Yuko, Umemura Shigeki, Nishino Kazumi, Nakachi Ichiro, Kuyama Shoichi, Daga Haruko, Hara Satoshi, Miyamoto Shingo, Kato Terufumi, Sakakibara-Konishi Jun, Tabata Eriko, Nakagawa Taku, Kawaguchi Tomoya, Sakai Tetsuya, Shibata Yuji, Izumi Hiroki, Nosaki Kaname, Zenke Yoshitaka, Yoh Kiyotaka, Goto Koic |
| UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 10 18 (2): 169-180. Bar Jair, Peled Nir, Schokrpur Shiruyeh, Wolner Mirjana, Rotem Ofer, Girard Nicolas, Aboubakar Nana Frank, Derijcke Sofie, Kian Waleed, Patel Sandip, Gantz-Sorotsky Hadas, Zer Alona, Moskovitz Mor, Metro Giulio, Rottenberg Yakir, Calles Antonio, Hochmair Maximilian, Cuppens Kristof, Decoster Lynn, Reck Martin, Limon Dror, Rodriguez Estelamari, Astaras Christoforos, Bettini Adrienne, Häfliger Simon, Addeo Alfre |
| Genomic landscape of lung cancer in the young. Frontiers in oncology 2022 12 910117. Ruiz Rossana, Galvez-Nino Marco, Roque Katia, Montes Jaime, Nuñez Maria, Raez Luis, Sánchez-Gambetta Sergio, Jaúregui Sandra, Viale Sandra, Smith Edward S, Pinto Joseph A, Mas Lu |
| Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 10 18 (1): 93-105. Zhou Caicun, Huang Dingzhi, Fan Yun, Yu Xinmin, Liu Yunpeng, Shu Yongqian, Ma Zhiyong, Wang Ziping, Cheng Ying, Wang Jie, Hu Sheng, Liu Zhihua, Poddubskaya Elena, Disel Umut, Akopov Andrey, Dvorkin Mikhail, Zheng Wenjuan, Ma Yiyuan, Wang Yan, Li Songzi, Yu Cunjing, Rivalland Gare |
| Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer. PloS one 2022 17 (10): e0276161. Chow Yock Ping, Zainul Abidin Norziha, Kow Ken Siong, Tho Lye Mun, Wong Chieh L |
| Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer. European journal of cancer (Oxford, England : 1990) 2023 5 188 81-89. Yiquan Xu, Jingjing Yan, Chengzhi Zhou, Lin Wu, Haibo Wang, Jun Zhao, Maolin Zhou, Jingyi Wang, Xinlong Zheng, Longfeng Zhang, Kan Jiang, Xiaobin Zheng, Qian Miao, Shiwen Wu, Zihua Zou, Rong Lian, Yuange He, Rongrong Chen, Shanshan Yang, Yujing Li, Sihui Chen, Gen L |
| Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets. Translational lung cancer research 2023 5 12 (4): 707-718. Midori Shimada, Hirokazu Taniguchi, Hiroyuki Yamaguchi, Hiroshi Gyotoku, Daisuke Sasaki, Norihito Kaku, Chikako Senju, Hiroaki Senju, Erika Imamura, Shinnosuke Takemoto, Kazuko Yamamoto, Noriho Sakamoto, Yasushi Obase, Tomoshi Tsuchiya, Minoru Fukuda, Hiroshi Soda, Kazuto Ashizawa, Junya Fukuoka, Takeshi Nagayasu, Katsunori Yanagihara, Hiroshi Muk |
| Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors. Cancer research communications 2023 4 3 (4): 532-539. Sun Boyang, Qiu Tian, Zeng Xiaoling, Duan Jianchun, Bai Hua, Xu Jiachen, Li Jin, Li Junling, Hao Xuezhi, Liu Yutao, Lin Lin, Wang Hongyu, Zhang Xin, Zhong Jia, Wang Jie, Ying Jianming, Wang Zhij |
| Durable Response to Chemoimmunotherapy of a Lung Adenocarcinoma Harboring a MET Exon 14 Skipping Mutation. Cureus 2023 4 15 (2): e35545. Nitta Naohiro, Morimoto Yoshie, Tani Nozomi, Shimamoto Takayu |
| A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US. Frontiers in genetics 2023 4 14 1141058. Breanna A James, Jennie L Williams, Barbara Nemesu |
| The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 2023 4 616 (7957): 525-533. Frankell Alexander M, Dietzen Michelle, Al Bakir Maise, Lim Emilia L, Karasaki Takahiro, Ward Sophia, Veeriah Selvaraju, Colliver Emma, Huebner Ariana, Bunkum Abigail, Hill Mark S, Grigoriadis Kristiana, Moore David A, Black James R M, Liu Wing Kin, Thol Kerstin, Pich Oriol, Watkins Thomas B K, Naceur-Lombardelli Cristina, Cook Daniel E, Salgado Roberto, Wilson Gareth A, Bailey Chris, Angelova Mihaela, Bentham Robert, Martínez-Ruiz Carlos, Abbosh Christopher, Nicholson Andrew G, Le Quesne John, Biswas Dhruva, Rosenthal Rachel, Puttick Clare, Hessey Sonya, Lee Claudia, Prymas Paulina, Toncheva Antonia, Smith Jon, Xing Wei, Nicod Jerome, Price Gillian, Kerr Keith M, Naidu Babu, Middleton Gary, Blyth Kevin G, Fennell Dean A, Forster Martin D, Lee Siow Ming, Falzon Mary, Hewish Madeleine, Shackcloth Michael J, Lim Eric, Benafif Sarah, Russell Peter, Boleti Ekaterini, Krebs Matthew G, Lester Jason F, Papadatos-Pastos Dionysis, Ahmad Tanya, Thakrar Ricky M, Lawrence David, Navani Neal, Janes Sam M, Dive Caroline, Blackhall Fiona H, Summers Yvonne, Cave Judith, Marafioti Teresa, Herrero Javier, Quezada Sergio A, Peggs Karl S, Schwarz Roland F, Van Loo Peter, Miedema Daniël M, Birkbak Nicolai J, Hiley Crispin T, Hackshaw Allan, Zaccaria Simone, , Jamal-Hanjani Mariam, McGranahan Nicholas, Swanton Charl |
| Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study. BMC cancer 2023 4 23 (1): 331. Hu Xingsheng, Cui Xinge, Wang Ziping, Liu Yunpeng, Luo Ying, Zhong Wei, Zhao Hui, Yao Mengxing, Jiang Da, Wang Mingxia, Chen Minjiang, Zheng Xin, Ding Lieming, Wang Yang, Yuan Xiaobin, Wu Pengxiang, Hu Bei, Han Xiaohong, Shi Yuank |
| Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib Plus Osimertinib in an EGFR-Mutation Positive, MET-Amplified Non-Small Cell Lung Cancer Model. Molecular cancer therapeutics 2023 3 . Jones Rhys D O, Petersson Klas, Tabatabai Areya, Bao Larry, Tomkinson Helen, Schuller Alwin |
| Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study. Frontiers in oncology 2023 3 13 1113696. Gow Chien-Hung, Hsieh Min-Shu, Chen Yi-Lin, Liu Yi-Nan, Wu Shang-Gin, Shih Jin-Yu |
| Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study. Cancer science 2023 2 . Qin Yi, Long Yaling, Tang Yuan, Tian Yuke, Li Juan, Duan Ping, Luo Jieyan, Yu Min, Li Yanying, Zhou Xiaojuan, Wang Ke, Gong Youling, Peng Feng, Zhu Jiang, Liu Yongmei, Zhou Lin, Lu You, Huang Meiju |
| Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial. Nature communications 2023 2 14 (1): 1071. Chmielecki Juliann, Mok Tony, Wu Yi-Long, Han Ji-Youn, Ahn Myung-Ju, Ramalingam Suresh S, John Thomas, Okamoto Isamu, Yang James Chih-Hsin, Shepherd Frances A, Bulusu Krishna C, Laus Gianluca, Collins Barbara, Barrett J Carl, Hartmaier Ryan J, Papadimitrakopoulou Vassili |
| Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature communications 2023 2 14 (1): 1070. Chmielecki Juliann, Gray Jhanelle E, Cheng Ying, Ohe Yuichiro, Imamura Fumio, Cho Byoung Chul, Lin Meng-Chih, Majem Margarita, Shah Riyaz, Rukazenkov Yuri, Todd Alexander, Markovets Aleksandra, Barrett J Carl, Hartmaier Ryan J, Ramalingam Suresh |
| An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples. Diagnostics (Basel, Switzerland) 2023 2 13 (4): . Bironzo Paolo, Pepe Francesco, Russo Gianluca, Pisapia Pasquale, Gragnano Gianluca, Aquino Gabriella, Bessi Silvia, Buglioni Simonetta, Bartoccini Federico, Ferrero Giuseppina, Bresciani Michela Anna, Francia di Celle Paola, Sibona Francesca, Giusti Andrea, Movilia Alessandra, Farioli Renata Mariella, Santoro Alessandra, Salemi Domenico, Scarpino Stefania, Galafate Dino, Tommasi Stefania, Lacalamita Rosanna, Seminati Davide, Sajjadi Elham, Novello Silvia, Pagni Fabio, Troncone Giancarlo, Malapelle Umber |
| Transient asymptomatic pulmonary opacities in a patient with MET exon 14 skipping non-small cell lung cancer: A case report. Thoracic cancer 2023 2 . Ikeo Satoshi, Yasuda Naoaki, Sakai Yuki, Hayashi Yasuyuki, Sokai Akihiko, Iwata Toshiyuki, Nishimura Takas |
| Molecular characteristics and prognostic factors of leptomeningeal metastasis in non-small cell lung cancer. Clinical neurology and neurosurgery 2023 1 225 107572. Liu Xiaocui, Li Guangrui, Zhang Hongmei, Chang Qing, Fang Mei, Lu Chufan, Tian Panpan, Mei Fengj |
| Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer. Respiratory research 2023 1 24 (1): 28. Yao Yu, Yang Huaping, Zhu Bo, Wang Song, Pang Jiaohui, Wu Xiaoying, Xu Yang, Zhang Junli, Zhang Jinfeng, Ou Qiuxiang, Tian Hui, Zhao Zhe |
| Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution. Heliyon 2023 1 8 (12): e12374. Yang Hainan, Wen Lei, Zhao Chao, Chen Jianing, Zhou Zhaoming, Zhou Cheng, Cai Linbo, Zhou Caic |
| Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: